Jagsonpal Pharmaceuticals dividend 2025

JAGSNPHARM

221.34

1.04 (-0.47%)
Last updated on 3 Oct, 2025 | 15:31 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Jagsonpal Pharmaceuticals Dividend Details

Record Date

12-Sep-2025

Ex Date

12-Sep-2025

Dividend Type

Equity Share

Dividend Per Share

125.00

Jagsonpal Pharmaceuticals Dividend History

Record DateDividend Per ShareDividend TypeEx-Date
12-Sep-20251.25Equity Share12-Sep-2025
06-Sep-20241.00Equity Share06-Sep-2024

Upcoming Dividends by Indian Companies

View More
CompanyDividends RatioAnnouncementRecord DateDividends Date
LTIMindtree Ltd.001-Oct-202524-Oct-202524-Oct-2025
ICICI Lombard General Insurance Company Ltd.025-Sep-202523-Oct-202523-Oct-2025
Tata Consultancy Services Ltd.022-Sep-202515-Oct-202515-Oct-2025
Rashtriya Chemicals and Fertilizers Ltd.0.13227-May-202510-Oct-202510-Oct-2025
Hexaware Technologies Ltd.5.7501-Oct-202510-Oct-202510-Oct-2025
CyberTech Systems And Software Ltd.229-Sep-202506-Oct-202506-Oct-2025

Jagsonpal Pharmaceuticals Dividend FAQs

The latest dividend declared by Jagsonpal Pharmaceuticals is of 1.25 per share for the financial year as announced on 12-Sep-2025.

Registered shareholders who own Jagsonpal Pharmaceuticals’s shares on or before the record date of 12-Sep-2025 set by the company are eligible to receive the dividend. You will not be entitled to the payout if you purchase shares on or after the ex-dividend date of 12-Sep-2025.

You can expect to receive Jagsonpal Pharmaceuticals’s dividend in your bank account linked to your Demat account within 25 to 45 business days after the record date of 12-Sep-2025. The record date is when Jagsonpal Pharmaceuticals identifies eligible shareholders for the dividend payment.

The annual dividend paid by Jagsonpal Pharmaceuticals varies according to its financial performance and dividend policy. Generally, companies in different sectors exhibit varying dividend yields. To determine Jagsonpal Pharmaceuticals's specific annual dividend, it’s advisable to consult the company's official investor relations website or recent financial statements.